DOI: 10.1055/s-00023610

Drug Research

References

Chen S, Zhao X, Wan J. et al.
Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.

Pharmacol Res 2015;
99: 74-81

Download Bibliographical Data

Access:
Access:
Access: